THE ROLE OF ISOCOLLOIDOOSMOTIC SYNTHETIC COLLOID ADDITION TO ST. THOMAS HOSPITAL CARDIOPLEGIC SOLUTION FOR CARDIOPROTECTION IN ISOLATED PERFUSED RAT HEARTS
Cardiac transplantation is a prominent development in the treatment of patients with severe cardiac diseases. If it is not possible to transplant the heart immediately after removing it from the donor, procedures for preparing, protecting, storing and transferring of the heart constitute a major por...
Gespeichert in:
Veröffentlicht in: | Pharmacological research 1997-07, Vol.36 (1), p.9-15 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 15 |
---|---|
container_issue | 1 |
container_start_page | 9 |
container_title | Pharmacological research |
container_volume | 36 |
creator | SÜ ZER, Ö NER Dİ Rİ, ERDAL KONUKOĞ LU, Dİ LDAR Ö ZÜ NER, ZEKİ |
description | Cardiac transplantation is a prominent development in the treatment of patients with severe cardiac diseases. If it is not possible to transplant the heart immediately after removing it from the donor, procedures for preparing, protecting, storing and transferring of the heart constitute a major portion of this study. Selecting the best method among those used for cardioprotection is still been debated. This experimental study investigated whether isocolloidoosmotic solution in addition to St. Thomas Hospital cardioplegic solution would give better cardioprotection. Wistar rat hearts were isolated and perfused by the Langendorff method (n=6 for each group). In the control group after stabilisation, the hearts were arrested while perfused with St. Thomas Hospital cardioplegic solution for 3 min, then they were placed in cardioplegic solution at 4°C for 6 h. Afterwards the hearts were reperfused. In the experimental groups, modified gelatin fluid (30 g/l) or HES 200/0.5 (50 g/l) or dextran 70 (25 g/l) was added to the cardioplegic solution. Maximum contractility, +dF/dtmax, −dF/dtmax, heart rate, contractility rate product, coronary flow and lactate dehydrogenase, creatine phosphokinase enzyme leakage were measured in all groups during pre-ischemic and post-ischemic periods (10 min after reperfusion). At the end of each experiment, the hearts were weighted and tissue levels of lipid peroxide, expressed in terms of thiobarbituric acid reactive substances, malondialdehyde, glutathione (an important intracellular antioxidant) and ATP were measured. Non-ischemic tissue levels of malondialdehyde, glutathione and ATP were also measured in another group (n=6). There was no statistically significant difference among the simultaneous experimental and control groups in any criteria evaluated (P>0.05). The addition of synthetic colloids to the standard cardioplegic solution did not provide further protection except for the gelatin group in which recovered contractile force was not significantly different from the group's initial values. This effect may be explained by its degradation to amino acids which may play a substrate role. |
doi_str_mv | 10.1006/phrs.1997.0206 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79423345</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1043661897902061</els_id><sourcerecordid>79423345</sourcerecordid><originalsourceid>FETCH-LOGICAL-c339t-5237233cefc4d8f1e8ab50a6850440ddd6acfc441f748317507b41536421989c3</originalsourceid><addsrcrecordid>eNp1kcFv2yAYxdG0qevaXXubxGk3exAwhqNlO7MlGiKbHHpCDsaqp6TJTFJpf8v-2eEm220nnnjv-32CB8ADRjFGiH07Pk8-xkKkMVog9g7cYiRYhDFn72dNScQY5h_BJ-9_IIQExegG3AjCuEDiFvzWVQkbJUuolrBuVa6kVHWhVPuodJ3D9mkVErO6OjArilrXagW1gq2Ooa7UY9bCSrXrWmcS5llT1Goty-_zuJKbt_BSNX-dRukyf7usV_NKmemygOuyWW7aIJpMw6rMGt3egw9Dt_Pu8_W8A5tlqfMqkiqwMxlZQsQpShYkXRBi3WBpzwfseLdNUMd4gihFfd-zzgaL4iGlnOA0QemW4oQwusCCC0vuwNcL9zgdfp6dP5n96K3b7boXdzh7kwoa-DQJwfgStNPB-8kN5jiN-276ZTAycxtmbsPMbZi5jTDw5Uo-b_eu_xe_fn_w-cV34Xmvo5uMt6N7sa4fJ2dPpj-M_0P_AXvCjMk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79423345</pqid></control><display><type>article</type><title>THE ROLE OF ISOCOLLOIDOOSMOTIC SYNTHETIC COLLOID ADDITION TO ST. THOMAS HOSPITAL CARDIOPLEGIC SOLUTION FOR CARDIOPROTECTION IN ISOLATED PERFUSED RAT HEARTS</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>SÜ ZER, Ö NER ; Dİ Rİ, ERDAL ; KONUKOĞ LU, Dİ LDAR ; Ö ZÜ NER, ZEKİ</creator><creatorcontrib>SÜ ZER, Ö NER ; Dİ Rİ, ERDAL ; KONUKOĞ LU, Dİ LDAR ; Ö ZÜ NER, ZEKİ</creatorcontrib><description>Cardiac transplantation is a prominent development in the treatment of patients with severe cardiac diseases. If it is not possible to transplant the heart immediately after removing it from the donor, procedures for preparing, protecting, storing and transferring of the heart constitute a major portion of this study. Selecting the best method among those used for cardioprotection is still been debated. This experimental study investigated whether isocolloidoosmotic solution in addition to St. Thomas Hospital cardioplegic solution would give better cardioprotection. Wistar rat hearts were isolated and perfused by the Langendorff method (n=6 for each group). In the control group after stabilisation, the hearts were arrested while perfused with St. Thomas Hospital cardioplegic solution for 3 min, then they were placed in cardioplegic solution at 4°C for 6 h. Afterwards the hearts were reperfused. In the experimental groups, modified gelatin fluid (30 g/l) or HES 200/0.5 (50 g/l) or dextran 70 (25 g/l) was added to the cardioplegic solution. Maximum contractility, +dF/dtmax, −dF/dtmax, heart rate, contractility rate product, coronary flow and lactate dehydrogenase, creatine phosphokinase enzyme leakage were measured in all groups during pre-ischemic and post-ischemic periods (10 min after reperfusion). At the end of each experiment, the hearts were weighted and tissue levels of lipid peroxide, expressed in terms of thiobarbituric acid reactive substances, malondialdehyde, glutathione (an important intracellular antioxidant) and ATP were measured. Non-ischemic tissue levels of malondialdehyde, glutathione and ATP were also measured in another group (n=6). There was no statistically significant difference among the simultaneous experimental and control groups in any criteria evaluated (P>0.05). The addition of synthetic colloids to the standard cardioplegic solution did not provide further protection except for the gelatin group in which recovered contractile force was not significantly different from the group's initial values. This effect may be explained by its degradation to amino acids which may play a substrate role.</description><identifier>ISSN: 1043-6618</identifier><identifier>EISSN: 1096-1186</identifier><identifier>DOI: 10.1006/phrs.1997.0206</identifier><identifier>PMID: 9368909</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Adenosine Triphosphate - metabolism ; Animals ; Bicarbonates - pharmacology ; Calcium Chloride - pharmacology ; cardiac protection ; cardioplegic solution ; Cardioplegic Solutions - pharmacology ; Colloids ; Coronary Circulation - drug effects ; Creatine Kinase - metabolism ; dextrans ; Female ; Gelatin ; gelatins ; Glutathione - metabolism ; Heart ; HES ; In Vitro Techniques ; L-Lactate Dehydrogenase - metabolism ; Magnesium - pharmacology ; Male ; Malondialdehyde - metabolism ; Myocardial Contraction - drug effects ; Myocardial Ischemia - metabolism ; Myocardial Reperfusion ; Myocardium - enzymology ; Myocardium - metabolism ; Organ Preservation - methods ; Potassium Chloride - pharmacology ; Rats ; Rats, Wistar ; Sodium Chloride - pharmacology ; St Thomas Hospital</subject><ispartof>Pharmacological research, 1997-07, Vol.36 (1), p.9-15</ispartof><rights>1997 The Italian Pharmacological Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c339t-5237233cefc4d8f1e8ab50a6850440ddd6acfc441f748317507b41536421989c3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1006/phrs.1997.0206$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9368909$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SÜ ZER, Ö NER</creatorcontrib><creatorcontrib>Dİ Rİ, ERDAL</creatorcontrib><creatorcontrib>KONUKOĞ LU, Dİ LDAR</creatorcontrib><creatorcontrib>Ö ZÜ NER, ZEKİ</creatorcontrib><title>THE ROLE OF ISOCOLLOIDOOSMOTIC SYNTHETIC COLLOID ADDITION TO ST. THOMAS HOSPITAL CARDIOPLEGIC SOLUTION FOR CARDIOPROTECTION IN ISOLATED PERFUSED RAT HEARTS</title><title>Pharmacological research</title><addtitle>Pharmacol Res</addtitle><description>Cardiac transplantation is a prominent development in the treatment of patients with severe cardiac diseases. If it is not possible to transplant the heart immediately after removing it from the donor, procedures for preparing, protecting, storing and transferring of the heart constitute a major portion of this study. Selecting the best method among those used for cardioprotection is still been debated. This experimental study investigated whether isocolloidoosmotic solution in addition to St. Thomas Hospital cardioplegic solution would give better cardioprotection. Wistar rat hearts were isolated and perfused by the Langendorff method (n=6 for each group). In the control group after stabilisation, the hearts were arrested while perfused with St. Thomas Hospital cardioplegic solution for 3 min, then they were placed in cardioplegic solution at 4°C for 6 h. Afterwards the hearts were reperfused. In the experimental groups, modified gelatin fluid (30 g/l) or HES 200/0.5 (50 g/l) or dextran 70 (25 g/l) was added to the cardioplegic solution. Maximum contractility, +dF/dtmax, −dF/dtmax, heart rate, contractility rate product, coronary flow and lactate dehydrogenase, creatine phosphokinase enzyme leakage were measured in all groups during pre-ischemic and post-ischemic periods (10 min after reperfusion). At the end of each experiment, the hearts were weighted and tissue levels of lipid peroxide, expressed in terms of thiobarbituric acid reactive substances, malondialdehyde, glutathione (an important intracellular antioxidant) and ATP were measured. Non-ischemic tissue levels of malondialdehyde, glutathione and ATP were also measured in another group (n=6). There was no statistically significant difference among the simultaneous experimental and control groups in any criteria evaluated (P>0.05). The addition of synthetic colloids to the standard cardioplegic solution did not provide further protection except for the gelatin group in which recovered contractile force was not significantly different from the group's initial values. This effect may be explained by its degradation to amino acids which may play a substrate role.</description><subject>Adenosine Triphosphate - metabolism</subject><subject>Animals</subject><subject>Bicarbonates - pharmacology</subject><subject>Calcium Chloride - pharmacology</subject><subject>cardiac protection</subject><subject>cardioplegic solution</subject><subject>Cardioplegic Solutions - pharmacology</subject><subject>Colloids</subject><subject>Coronary Circulation - drug effects</subject><subject>Creatine Kinase - metabolism</subject><subject>dextrans</subject><subject>Female</subject><subject>Gelatin</subject><subject>gelatins</subject><subject>Glutathione - metabolism</subject><subject>Heart</subject><subject>HES</subject><subject>In Vitro Techniques</subject><subject>L-Lactate Dehydrogenase - metabolism</subject><subject>Magnesium - pharmacology</subject><subject>Male</subject><subject>Malondialdehyde - metabolism</subject><subject>Myocardial Contraction - drug effects</subject><subject>Myocardial Ischemia - metabolism</subject><subject>Myocardial Reperfusion</subject><subject>Myocardium - enzymology</subject><subject>Myocardium - metabolism</subject><subject>Organ Preservation - methods</subject><subject>Potassium Chloride - pharmacology</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Sodium Chloride - pharmacology</subject><subject>St Thomas Hospital</subject><issn>1043-6618</issn><issn>1096-1186</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kcFv2yAYxdG0qevaXXubxGk3exAwhqNlO7MlGiKbHHpCDsaqp6TJTFJpf8v-2eEm220nnnjv-32CB8ADRjFGiH07Pk8-xkKkMVog9g7cYiRYhDFn72dNScQY5h_BJ-9_IIQExegG3AjCuEDiFvzWVQkbJUuolrBuVa6kVHWhVPuodJ3D9mkVErO6OjArilrXagW1gq2Ooa7UY9bCSrXrWmcS5llT1Goty-_zuJKbt_BSNX-dRukyf7usV_NKmemygOuyWW7aIJpMw6rMGt3egw9Dt_Pu8_W8A5tlqfMqkiqwMxlZQsQpShYkXRBi3WBpzwfseLdNUMd4gihFfd-zzgaL4iGlnOA0QemW4oQwusCCC0vuwNcL9zgdfp6dP5n96K3b7boXdzh7kwoa-DQJwfgStNPB-8kN5jiN-276ZTAycxtmbsPMbZi5jTDw5Uo-b_eu_xe_fn_w-cV34Xmvo5uMt6N7sa4fJ2dPpj-M_0P_AXvCjMk</recordid><startdate>19970701</startdate><enddate>19970701</enddate><creator>SÜ ZER, Ö NER</creator><creator>Dİ Rİ, ERDAL</creator><creator>KONUKOĞ LU, Dİ LDAR</creator><creator>Ö ZÜ NER, ZEKİ</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19970701</creationdate><title>THE ROLE OF ISOCOLLOIDOOSMOTIC SYNTHETIC COLLOID ADDITION TO ST. THOMAS HOSPITAL CARDIOPLEGIC SOLUTION FOR CARDIOPROTECTION IN ISOLATED PERFUSED RAT HEARTS</title><author>SÜ ZER, Ö NER ; Dİ Rİ, ERDAL ; KONUKOĞ LU, Dİ LDAR ; Ö ZÜ NER, ZEKİ</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c339t-5237233cefc4d8f1e8ab50a6850440ddd6acfc441f748317507b41536421989c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Adenosine Triphosphate - metabolism</topic><topic>Animals</topic><topic>Bicarbonates - pharmacology</topic><topic>Calcium Chloride - pharmacology</topic><topic>cardiac protection</topic><topic>cardioplegic solution</topic><topic>Cardioplegic Solutions - pharmacology</topic><topic>Colloids</topic><topic>Coronary Circulation - drug effects</topic><topic>Creatine Kinase - metabolism</topic><topic>dextrans</topic><topic>Female</topic><topic>Gelatin</topic><topic>gelatins</topic><topic>Glutathione - metabolism</topic><topic>Heart</topic><topic>HES</topic><topic>In Vitro Techniques</topic><topic>L-Lactate Dehydrogenase - metabolism</topic><topic>Magnesium - pharmacology</topic><topic>Male</topic><topic>Malondialdehyde - metabolism</topic><topic>Myocardial Contraction - drug effects</topic><topic>Myocardial Ischemia - metabolism</topic><topic>Myocardial Reperfusion</topic><topic>Myocardium - enzymology</topic><topic>Myocardium - metabolism</topic><topic>Organ Preservation - methods</topic><topic>Potassium Chloride - pharmacology</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Sodium Chloride - pharmacology</topic><topic>St Thomas Hospital</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SÜ ZER, Ö NER</creatorcontrib><creatorcontrib>Dİ Rİ, ERDAL</creatorcontrib><creatorcontrib>KONUKOĞ LU, Dİ LDAR</creatorcontrib><creatorcontrib>Ö ZÜ NER, ZEKİ</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pharmacological research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SÜ ZER, Ö NER</au><au>Dİ Rİ, ERDAL</au><au>KONUKOĞ LU, Dİ LDAR</au><au>Ö ZÜ NER, ZEKİ</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>THE ROLE OF ISOCOLLOIDOOSMOTIC SYNTHETIC COLLOID ADDITION TO ST. THOMAS HOSPITAL CARDIOPLEGIC SOLUTION FOR CARDIOPROTECTION IN ISOLATED PERFUSED RAT HEARTS</atitle><jtitle>Pharmacological research</jtitle><addtitle>Pharmacol Res</addtitle><date>1997-07-01</date><risdate>1997</risdate><volume>36</volume><issue>1</issue><spage>9</spage><epage>15</epage><pages>9-15</pages><issn>1043-6618</issn><eissn>1096-1186</eissn><abstract>Cardiac transplantation is a prominent development in the treatment of patients with severe cardiac diseases. If it is not possible to transplant the heart immediately after removing it from the donor, procedures for preparing, protecting, storing and transferring of the heart constitute a major portion of this study. Selecting the best method among those used for cardioprotection is still been debated. This experimental study investigated whether isocolloidoosmotic solution in addition to St. Thomas Hospital cardioplegic solution would give better cardioprotection. Wistar rat hearts were isolated and perfused by the Langendorff method (n=6 for each group). In the control group after stabilisation, the hearts were arrested while perfused with St. Thomas Hospital cardioplegic solution for 3 min, then they were placed in cardioplegic solution at 4°C for 6 h. Afterwards the hearts were reperfused. In the experimental groups, modified gelatin fluid (30 g/l) or HES 200/0.5 (50 g/l) or dextran 70 (25 g/l) was added to the cardioplegic solution. Maximum contractility, +dF/dtmax, −dF/dtmax, heart rate, contractility rate product, coronary flow and lactate dehydrogenase, creatine phosphokinase enzyme leakage were measured in all groups during pre-ischemic and post-ischemic periods (10 min after reperfusion). At the end of each experiment, the hearts were weighted and tissue levels of lipid peroxide, expressed in terms of thiobarbituric acid reactive substances, malondialdehyde, glutathione (an important intracellular antioxidant) and ATP were measured. Non-ischemic tissue levels of malondialdehyde, glutathione and ATP were also measured in another group (n=6). There was no statistically significant difference among the simultaneous experimental and control groups in any criteria evaluated (P>0.05). The addition of synthetic colloids to the standard cardioplegic solution did not provide further protection except for the gelatin group in which recovered contractile force was not significantly different from the group's initial values. This effect may be explained by its degradation to amino acids which may play a substrate role.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>9368909</pmid><doi>10.1006/phrs.1997.0206</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1043-6618 |
ispartof | Pharmacological research, 1997-07, Vol.36 (1), p.9-15 |
issn | 1043-6618 1096-1186 |
language | eng |
recordid | cdi_proquest_miscellaneous_79423345 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Adenosine Triphosphate - metabolism Animals Bicarbonates - pharmacology Calcium Chloride - pharmacology cardiac protection cardioplegic solution Cardioplegic Solutions - pharmacology Colloids Coronary Circulation - drug effects Creatine Kinase - metabolism dextrans Female Gelatin gelatins Glutathione - metabolism Heart HES In Vitro Techniques L-Lactate Dehydrogenase - metabolism Magnesium - pharmacology Male Malondialdehyde - metabolism Myocardial Contraction - drug effects Myocardial Ischemia - metabolism Myocardial Reperfusion Myocardium - enzymology Myocardium - metabolism Organ Preservation - methods Potassium Chloride - pharmacology Rats Rats, Wistar Sodium Chloride - pharmacology St Thomas Hospital |
title | THE ROLE OF ISOCOLLOIDOOSMOTIC SYNTHETIC COLLOID ADDITION TO ST. THOMAS HOSPITAL CARDIOPLEGIC SOLUTION FOR CARDIOPROTECTION IN ISOLATED PERFUSED RAT HEARTS |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T00%3A55%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=THE%20ROLE%20OF%20ISOCOLLOIDOOSMOTIC%20SYNTHETIC%20COLLOID%20ADDITION%20TO%20ST.%20THOMAS%20HOSPITAL%20CARDIOPLEGIC%20SOLUTION%20FOR%20CARDIOPROTECTION%20IN%20ISOLATED%20PERFUSED%20RAT%20HEARTS&rft.jtitle=Pharmacological%20research&rft.au=S%C3%9C%20ZER,%20%C3%96%20NER&rft.date=1997-07-01&rft.volume=36&rft.issue=1&rft.spage=9&rft.epage=15&rft.pages=9-15&rft.issn=1043-6618&rft.eissn=1096-1186&rft_id=info:doi/10.1006/phrs.1997.0206&rft_dat=%3Cproquest_cross%3E79423345%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79423345&rft_id=info:pmid/9368909&rft_els_id=S1043661897902061&rfr_iscdi=true |